|
|
||||||||
1 The Research and Development Group, Department of Clinical Chemistry, Ullevål University Hospital, 0407 Oslo, Norway.
aAuthor for correspondence. Fax 47-22118189; e-mail reidun.ovstebo{at}ioks.uio.no.
Background: Quantitative reverse transcription-PCR (RT-PCR) used to detect small changes in specific mRNA concentrations is often associated with poor reproducibility. Thus, there is a need for stringent quality control in each step of the protocol.
Methods: Real-time PCR-based calibration curves for a target gene, tissue factor (TF), and a reference gene, ß-actin, generated from PCR amplicons were evaluated by running cDNA controls. In addition, the reverse transcription step was evaluated by running mRNA controls. Amplification efficiencies of calibrators and targets were determined. Variances within and between runs were estimated, and power statistics were applied to determine the concentration differences that could reliably be detected.
Results: Within- and between-run variations (CVs) of cDNA controls (TF and ß-actin), extrapolated from reproducible calibration curves (CVs of slopes, 4.3% and 2.7%, respectively) were 410% (within) and 1538% (between) using both daily and "grand mean" calibration curves. CVs for the ß-actin mRNA controls were 12% (within) and 1928% (between). Estimates of each steps contribution to the total variation were as follows: CVRT-PCR, 28%; CVPCR, 15%; CVRT, 23% (difference between CVRT-PCR and CVPCR). PCR efficiencies were as follows: ß-actin calibrator/target, 1.96/1.95; TF calibrator/target, 1.95/1.93. Duplicate measurements could detect a twofold concentration difference (power, 0.8).
Conclusions: Daily PCR calibration curves generated from PCR amplicons were reproducible, allowing the use of a grand mean calibration curve. The reverse transcription step contributes the most to the total variation. By determining a systems total variance, power analysis may be used to disclose differences that can be reliably detected at a specified power.
The following articles in journals at HighWire Press have cited this article:
![]() |
T. P. Utheim, S. Raeder, O. K. Olstad, O. A. Utheim, M. de La Paz, R. Cheng, T. T. Huynh, E. Messelt, B. Roald, and T. Lyberg Comparison of the Histology, Gene Expression Profile, and Phenotype of Cultured Human Limbal Epithelial Cells from Different Limbal Regions Invest. Ophthalmol. Vis. Sci., November 1, 2009; 50(11): 5165 - 5172. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Horst, D. van Leeuwen, N. P. Croft, M. A. Garstka, A. D. Hislop, E. Kremmer, A. B. Rickinson, E. J. H. J. Wiertz, and M. E. Ressing Specific Targeting of the EBV Lytic Phase Protein BNLF2a to the Transporter Associated with Antigen Processing Results in Impairment of HLA Class I-Restricted Antigen Presentation J. Immunol., February 15, 2009; 182(4): 2313 - 2324. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Sheffield, G. D. Wendel Jr, D. D. McIntire, and M. V. Norgard The Effect of Progesterone Levels and Pregnancy on HIV-1 Coreceptor Expression Reproductive Sciences, January 1, 2009; 16(1): 20 - 31. [Abstract] [PDF] |
||||
![]() |
L. Struijk, E. van der Meijden, S. Kazem, J. ter Schegget, F. R. de Gruijl, R. D. M. Steenbergen, and M. C. W. Feltkamp Specific betapapillomaviruses associated with squamous cell carcinoma of the skin inhibit UVB-induced apoptosis of primary human keratinocytes J. Gen. Virol., September 1, 2008; 89(9): 2303 - 2314. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Woelfelschneider, O. Popanda, C. Lilla, J. Linseisen, C. Mayer, O. Celebi, J. Debus, H. Bartsch, J. Chang-Claude, and P. Schmezer A distinct ERCC1 haplotype is associated with mRNA expression levels in prostate cancer patients Carcinogenesis, September 1, 2008; 29(9): 1758 - 1764. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ovstebo, O. K. Olstad, B. Brusletto, A. S. Moller, A. Aase, K. B. F. Haug, P. Brandtzaeg, and P. Kierulf Identification of Genes Particularly Sensitive to Lipopolysaccharide (LPS) in Human Monocytes Induced by Wild-Type versus LPS-Deficient Neisseria meningitidis Strains Infect. Immun., June 1, 2008; 76(6): 2685 - 2695. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Krop, A. Marz, H. Carlsson, X. Li, N. Bloushtain-Qimron, M. Hu, R. Gelman, M. S. Sabel, S. Schnitt, S. Ramaswamy, et al. A Putative Role for Psoriasin in Breast Tumor Progression Cancer Res., December 15, 2005; 65(24): 11326 - 11334. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Zygalaki, A. Stathopoulou, C. Kroupis, L. Kaklamanis, Z. Kyriakides, D. Kremastinos, and E. S. Lianidou Real-Time Reverse Transcription-PCR Quantification of Vascular Endothelial Growth Factor Splice Variants Clin. Chem., August 1, 2005; 51(8): 1518 - 1520. [Full Text] [PDF] |
||||
![]() |
A.-K. Fjeldheim, P. I. Hovring, O.-P. Loseth, P. W. Johansen, J. C Glover, V. Matre, O. K. Olstad, S. Reppe, J. O Gordeladze, S I. Walaas, et al. Thyrotrophin-releasing hormone receptor 1 and prothyrotrophin-releasing hormone mRNA expression in the central nervous system are regulated by suckling in lactating rats Eur. J. Endocrinol., May 1, 2005; 152(5): 791 - 803. [Abstract] [Full Text] [PDF] |
||||
![]() |
P de Cremoux, I Bieche, C Tran-Perennou, S Vignaud, E Boudou, B Asselain, R Lidereau, H Magdelenat, V Becette, B Sigal-Zafrani, et al. Inter-laboratory quality control for hormone-dependent gene expression in human breast tumors using real-time reverse transcription-polymerase chain reaction Endocr. Relat. Cancer, September 1, 2004; 11(3): 489 - 495. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ovstebo, P. Brandtzaeg, B. Brusletto, K. B. F. Haug, K. Lande, E. A. Hoiby, and P. Kierulf Use of Robotized DNA Isolation and Real-Time PCR To Quantify and Identify Close Correlation between Levels of Neisseria meningitidis DNA and Lipopolysaccharides in Plasma and Cerebrospinal Fluid from Patients with Systemic Meningococcal Disease J. Clin. Microbiol., July 1, 2004; 42(7): 2980 - 2987. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-S. W. Moller, R. Ovstebo, A.-B. Westvik, G. B. Joo, K.-B. F. Haug, and P. Kierulf Effects of bacterial cell wall components (PAMPs) on the expression of monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1{alpha} (MIP-1{alpha}) and the chemokine receptor CCR2 by purified human blood monocytes Innate Immunity, December 1, 2003; 9(6): 349 - 360. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |